Sponsor pipeline

Todd C. Lee MD MPH FIDSA clinical trial pipeline

Get alerts when Todd C. Lee MD MPH FIDSA's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 1 stopped, 0 with notable changes, 0 with minor changes only.

  1. Stopped

    Trial terminated

    Sponsor's reason: After reviewing the recruitment to date as well as considering the anticipated ongoing recruitment challenges and feasibility, the decision was made to close the study.

    Also in this update: Final enrollment: 1 participants — under 1% of the 330 planned; Primary completion date changed from estimate of Dec 2029 to Sep 14, 2026

    Todd C. Lee MD MPH FIDSAPhase 3 NCT07253688 Registry history

    Updated

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
1
Phase 3
1
Phase 4
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06650488 Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus… Staphylococcus Aureus Endocarditis Recruiting 2026-09-24
NCT06637332 Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia Staphylococcus Aureus Septicemia Recruiting 2026-09-09
Phase 3
NCT04851015 Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii… Pneumocystis Recruiting 2026-02-20
Phase 2
NCT04886284 Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus… Staphylococcus Aureus Bacteremia Recruiting 2026-09-11
Get alerts when Todd C. Lee MD MPH FIDSA's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free